Control programs for infectious bovine rhinotracheitis (IBR) in European countries: an overview.
Control program
Europe
IBR
eradication
Journal
Animal health research reviews
ISSN: 1475-2654
Titre abrégé: Anim Health Res Rev
Pays: England
ID NLM: 101083072
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
25
1
2022
pubmed:
26
1
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
Infectious bovine rhinotracheitis (IBR), caused by Bovine alphaherpesvirus 1 (BoHV-1), is a disease of cattle responsible for significant economic losses worldwide. IBR is under certain communitarian regulations. Every member state can approve its own national IBR control program for the entire territory - or part of it - and can demand additional guarantees for bovids destined to its territory; therefore, every member state can be officially declared as entirely or partly IBR-free. The aim of this review is to provide an overview of IBR control and eradication programs in European countries. BoHV-1 control schemes were first introduced in the late 1970s, mainly in Northern and Central Europe. Depending on the seroprevalence rate, control strategies rely on identification and removal of seropositive animals or the use of glycoprotein E (gE)-deleted marker vaccines in infected herds. The implementation of a novel law for disease eradication at the EU level and of a European IBR data flow could make the goal of IBR eradication in all European countries easier to achieve.
Identifiants
pubmed: 35076360
doi: 10.1017/S1466252321000116
pii: S1466252321000116
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM